لابراتوارهای دارویی رازک

درازک | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: 5,650 2.92

Close Price: 5,680

	2026/07/19 Fiscal Year 2026/03/2012 Month	2025/06/17 Fiscal Year 2025/03/2012 Month	2024/07/31 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	21.96	0.1	2.05
Gross Profit to Sales	23.45	2.25	9.01
Operating Margin	25.67	3.75	10.9
Gross Profit to Sales	31.66	13.51	19.78
Net Profit to Gross Profit	69.37	0.74	10.35
Return on Assets (ROA)	10.34	0.03	0.85
Return on Capital (%)	25.98	0.52	10.38
Return on Equity (ROE)	20.35	0.06	7.76
Working Capital Return	54.18	0.54	10.06
Fixed Asset Return	28.69	0.07	38.55
Loan Benefit Assessment	1.97	2.27	9.1
Current Ratio	1.44	1.09	1.1
Quick Ratio	1.13	0.86	0.88
Liquidity Ratio	0.02	0	0
Net Working Capital	8,356,743	2,047,206	2,167,019
Current Assets Ratio	0.63	0.59	0.96
Inventory Turnover	143.25	194.15	162.93
Receivables Collection Period	363.98	595.74	613.99
Inventory to Working Capital	0.7	2.53	2.28
Working Capital Turnover	2.47	5.37	4.91
Fixed Asset Turnover	1.31	0.7	18.83
Total Asset Turnover	0.47	0.27	0.42
Debt Ratio	0.49	0.56	0.89
Debt to Equity	0.97	1.27	8.1
Long-Term Debt to Equity	0.11	0.03	0.15
Current Debt to Equity	0.86	1.23	7.94
Equity Ratio	50.83	44.15	10.99
Debt Coverage Ratio	6.35	26.42	1.31

At a Glance